Stock Information

This section of the Evofem Investor Room houses the most recently available financial reporting information and interactive tools for analyzation of stock performance.  
Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Evofem assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQEVFM
Beta2.56
Shares Outstanding17.8M
Average Volume (10 days)24.6K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($4.33)
Sales (TTM)--
Book Value (MRQ)$0.15
Cash Flow (TTM)($3.56)
Cash (MRQ)$1.48

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy1
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Susan A. Knudson
Chief Financial Officer
(1,005)
Sell
Dec 17, 2015
Kenneth W. Locke
Chief Scientific Officer
(598)
Sell
Dec 17, 2015
Farah Champsi
Ten Percent Owner
(529,261)
Sell
Dec 15, 2015
Kenneth W. Locke
Chief Scientific Officer
(6,098)
Sell
Nov 18, 2015
George W. Mahaffey
Director, President and CEO
(26,681)
Dispose
Oct 15, 2015

Recent SEC Filings

Company Events
May 22, 2018
POS EX
May 22, 2018
EFFECT
May 21, 2018
RW
May 16, 2018
Company Events
May 16, 2018